HR
MEDP icon

Hardy Reed’s Medpace MEDP Stock Holding History

Hardy Reed’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Hold
632
– – 0.02% 189
2026
Q1 		$303K Sell
632
-4
-0.6% -$2.05K 0.02% 188
2025
Q4 		$357K Buy
636
+4
+0.6% +$2.27K 0.03% 179
2025
Q3 		$325K Sell
632
-105
-14% -$45.8K 0.02% 187
2025
Q2 		$231K Hold
737
– – 0.02% 223
2025
Q1 		$225K Hold
737
– – 0.02% 217
2024
Q4 		$245K Hold
737
– – 0.02% 215
2024
Q3 		$246K Hold
737
– – 0.02% 216
2024
Q2 		$304K Sell
737
-130
-15% -$51.5K 0.03% 181
2024
Q1 		$350K Sell
867
-166
-16% -$58.4K 0.04% 82
2023
Q4 		$317K Sell
1,033
-5
-0.5% -$1.35K 0.04% 90
2023
Q3 		$251K Hold
1,038
– – 0.05% 85
2023
Q2 		$249K Buy
+1,038
New +$216K 0.04% 82

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Hardy Reed's MEDP Position: Q2 2026 in Review

Hardy Reed held its Medpace (MEDP) position steady in Q2 2026 at 632 shares worth $335K. The position accounts for 0.02% of the portfolio, ranked #189.

Hardy Reed first reported a position in MEDP in Q2 2023 and has held it in 13 quarters since. The position peaked at $357K in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Hardy Reed held 632 shares of Medpace worth $335K as of Q2 2026.
  • Hardy Reed left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.02% of Hardy Reed's portfolio in Q2 2026, its #189 holding.
  • Hardy Reed first reported a position in Medpace in Q2 2023 and has held it in 13 quarters since.
  • Hardy Reed's Medpace position peaked at $357K in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.